Spanish for diabetes education nurses — the type 2 patient who has refused insulin for three years because her family believes starting insulin means she has failed, the type 1 patient who is rationing his insulin to stretch a vial across two weeks because he cannot afford the refill, and the type 2 patient who has brought a beautiful handwritten glucose log to every appointment for eighteen months but has never been told what to do with a number above 200

Why these three conversations

Esperanza Gutiérrez is fifty-eight years old. She runs a bakery — pan dulce, conchas, tres leches on Sundays — in the Oak Park neighborhood of Sacramento, California. She opened it twenty-three years ago with her husband Roberto after they arrived from Guanajuato, first in a rented kitchen, then in a small storefront, then in the larger space where she now employs her daughter-in-law and two neighbors. The bakery opens at six. She is there at four-thirty. She is the first one in and usually the last one out. She has had type 2 diabetes for eleven years. She manages it with metformin 2,000 mg daily and glipizide 10 mg twice daily and a diet she describes as “cuidadosa” (careful), which it is: she has removed white rice from the family dinner, replaced pan dulce with fruit on most mornings, and walks forty minutes every evening after closing. She attends every clinic appointment. She brings her glucose log. She has done everything she was told to do.

Her A1C today is 11.2. It was 10.8 three months ago, and 10.4 six months before that. Her primary care physician has suggested insulin at three consecutive visits. She has declined each time. At the first suggestion, she said she would try harder with the diet. At the second, she asked for a different pill. At the third, she accepted a referral to diabetes education — not because she is open to insulin, but because the referral felt like a compromise. She arrives at the diabetes education clinic at Mission Neighborhood Health Center with a glucose log, a small notebook, and a clear position: she is not starting insulin. Her sister started insulin six years ago and died of kidney failure three years later. Her mother started insulin in her sixties and never walked without a walker again. Insulin is not a medication in her family. It is a marker of where the road ends.

Carlos Morales is forty-four years old. He is a construction worker from Houston, Texas — concrete crew, foundations and slabs, work that starts before sunrise when the pavement is cool enough to touch. He has had type 1 diabetes for eighteen years, diagnosed at twenty-six when he collapsed on a job site and was taken to Ben Taub General and told his blood sugar was 724. He manages his diabetes with basal-bolus insulin: twenty-eight units of insulin glargine at night, a carbohydrate ratio for bolus dosing with meals. He has a glucometer. He checks. He has had three hospitalizations for diabetic ketoacidosis in the last two years: once in February, once in August of last year, once in January. At each hospitalization, the medical team reviewed his insulin regimen, confirmed the doses were appropriate, and discharged him with the same prescription. At each discharge, the nurse asked if he had questions about his medications. He said no. At each follow-up appointment, his provider asked if he was taking his insulin as prescribed. He said yes.

He was not lying. He was taking the insulin he had. What he was not saying — what no one had asked, in the specific way that the answer requires — was that he runs out of insulin glargine approximately ten days before the end of each month. His insurance covers thirty days of insulin; the copay is $68 per vial. On the weeks when a paycheck is short, or when the truck needs a repair, or when a child is sick and there are pharmacy costs, $68 does not exist. He stretches the vial. He takes sixteen units instead of twenty-eight. He sometimes takes twelve. He skips the night dose entirely on the nights when the vial is gone and tells himself he will start again tomorrow when he can get to the pharmacy. Three times in two years, the glucose has climbed past 400 and his wife has driven him to the emergency room at midnight with his legs shaking and his breath smelling wrong. Three times, the chart has recorded “DKA, etiology unclear.”

Rosa Jiménez is sixty-seven years old. She taught third grade at an elementary school in the South Valley of Albuquerque, New Mexico for thirty-one years. She retired four years ago. She reads everything. She has had type 2 diabetes for nine years. She manages it with metformin 1,000 mg twice daily and sitagliptin 100 mg daily. She has a glucose meter — she was given one at diagnosis and shown how to use it. She was told to check every morning before breakfast and two hours after dinner. She has done this every day for nine years. She keeps a handwritten log in a spiral notebook: date, fasting glucose, post-dinner glucose, two-hour postmeal when she remembers to check it, a column for notes (“comida pesada,” “no caminé,” “mal sueño”). The notebook is organized, consistent, and detailed. She brings it to every appointment.

Her A1C today is 9.1. It has been between 8.8 and 9.4 for four years. At every appointment, a provider or nurse asks if she is checking her blood sugar. She says yes and shows the notebook. The provider nods and writes the number down and says “a ver si podemos bajar ese número” (let’s see if we can bring that number down) and adjusts a dose. Rosa goes home and checks her blood sugar at six-thirty in the morning and two hours after dinner, writes the numbers in the notebook, and does exactly what she did the day before. No one has told her that 247 after breakfast means she should eat a smaller breakfast, or that 189 before bed means the dinner starch was larger than the sitagliptin could handle, or that 73 on a Wednesday morning when she had been sick and not eating is the number that means she should drink four ounces of juice immediately and recheck in fifteen minutes. She has nine years of numbers. She has never been taught to read them.

These three patients have different diabetes, different barriers, and different relationships with their care. What they share is a conversation that has not happened — a specific exchange with someone who understands the mechanism behind the number, speaks their language, and can translate the mechanism into something they can act on. The certified diabetes care and education specialist is that person.

Scenario 1 — Esperanza Gutiérrez, 58, type 2 diabetes for eleven years, A1C 11.2, bakery owner, who told the diabetes educator “I am not starting insulin” before she sat down

Diana Villanueva has been a certified diabetes care and education specialist at Mission Neighborhood Health Center in Sacramento for nine years. She has had the insulin conversation hundreds of times. She has learned that the conversation that matters is not the one about insulin. It is the one about what the patient believes insulin means. If she begins with the mechanism — the pancreas, the beta cells, the glargine pharmacokinetics — Esperanza will hear her and disagree more firmly. The mechanism is correct but irrelevant to the belief that insulin is where the road ends. Diana has to find out where that belief came from before she can say anything clinical.

She introduces herself, asks Esperanza to sit down, and says nothing about insulin for the first twelve minutes. She asks about the bakery. She asks what Esperanza makes on Saturday mornings. She asks about the forty-minute evening walk, which she genuinely admires — forty minutes of walking every evening after a day of baking is not nothing. She asks about the glucose log. She looks at it. She is reading a story of consistent effort: the diet modifications, the exercise, the medication adherence, eleven years of trying, and an A1C that is moving in the wrong direction regardless.

Then she asks the question she has been building toward.

Diana: “Quiero entender mejor lo que siente cuando el médico menciona la insulina. No para convencerla de nada — solo para entender. ¿Qué es lo primero que piensa cuando escucha esa palabra?”

(I want to understand better what you feel when the doctor mentions insulin. Not to convince you of anything — just to understand. What is the first thing you think when you hear that word?)

Esperanza is quiet for a moment. Then she tells her about her sister. And then about her mother.

The insulin that preceded everything that went wrong

Her sister Patricia started insulin six years ago, after years of escalating oral medications and an A1C that stopped responding. Three years later she had stage four kidney disease. She died in 2023. The insulin came before the kidney failure. In Esperanza’s understanding, the insulin produced the kidney failure. Her mother started insulin at sixty-two and began using a walker at sixty-eight because of peripheral neuropathy. The insulin came before the walker. In Esperanza’s understanding, the insulin produced the neuropathy.

Diana listens. She does not interrupt. When Esperanza finishes, she says this:

Diana: “Gracias por contarme eso. Eso es lo más importante que me ha dicho hoy. Y lo que voy a decirle es importante que lo escuche con todo esto en mente.”

(Thank you for telling me that. That is the most important thing you have told me today. And what I am going to say to you is important to hear with all of this in mind.)

She pauses.

Diana: “Lo que le pasó a su hermana y a su mamá no fue causado por la insulina. Lo que les pasó fue causado por la glucosa alta que llegó antes de la insulina — los años en que la glucosa estuvo elevada mientras los médicos intentaban controlarlo con pastillas. La glucosa alta daña los riñones. La glucosa alta daña los nervios. La insulina no fue la causa — fue el último intento de bajar una glucosa que ya había estado alta demasiado tiempo.”

(What happened to your sister and your mother was not caused by insulin. What happened to them was caused by the high glucose that came before the insulin — the years when glucose was elevated while the doctors tried to control it with pills. High glucose damages the kidneys. High glucose damages the nerves. Insulin was not the cause — it was the last attempt to lower a glucose that had already been high for too long.)

Esperanza: “Pero empezaron la insulina y después les pasó todo eso.”

(But they started insulin and then all of that happened to them.)

Diana: “Sí. Porque la insulina llegó tarde. Los riñones y los nervios ya llevaban años expuestos a la glucosa alta. La insulina no puede deshacer lo que la glucosa alta hizo en esos años. Lo que puede hacer es detener que siga pasando.”

(Yes. Because insulin arrived late. The kidneys and the nerves had already been exposed to high glucose for years. Insulin cannot undo what high glucose did in those years. What it can do is stop it from continuing to happen.)

The pancreas that has been working eleven years and is tired

Diana draws a simple diagram: a circle (the pancreas), small dots inside it (beta cells), and an arrow pointing down with years marked along it: 2015, 2018, 2021, 2024, 2026.

Diana: “La diabetes tipo dos empieza cuando el cuerpo deja de responder bien a la insulina que el páncreas produce — eso se llama resistencia a la insulina. Al principio, el páncreas compensa produciendo más insulina para superar la resistencia. Con los años, las células beta que producen la insulina se agotan de tanto trabajar. Esto pasa en todas las personas con diabetes tipo dos. No porque coman mal. No porque no hagan ejercicio. Porque es la progresión natural de la enfermedad. Después de once años, el páncreas de usted produce una fracción de la insulina que producía cuando empezó. La metformina y el glipizide son medicamentos que ayudan a ese páncreas a trabajar mejor — pero cuando el páncreas ya no tiene suficiente insulina que producir, esos medicamentos no pueden compensar lo que no existe.”

(Type 2 diabetes begins when the body stops responding well to the insulin the pancreas produces — that is called insulin resistance. At first, the pancreas compensates by producing more insulin to overcome the resistance. Over the years, the beta cells that produce insulin exhaust themselves from so much work. This happens to all people with type 2 diabetes. Not because they eat badly. Not because they do not exercise. Because it is the natural progression of the disease. After eleven years, your pancreas produces a fraction of the insulin it produced when you started. Metformin and glipizide are medications that help that pancreas work better — but when the pancreas no longer has enough insulin to produce, those medications cannot compensate for what does not exist.)

Esperanza: “¿Entonces no importa lo que yo haga?”

(So nothing I do matters?)

Diana: “Todo lo que usted hace importa. La dieta, el ejercicio, la metformina — eso es lo que mantuvo su A1C donde está en lugar de donde podría estar. Sin todo eso, el número sería mucho mayor. Lo que pasa es que la enfermedad progresó de todas formas, porque siempre progresa. Usted no llegó al 11.2 porque algo falló de su parte. Llegó al 11.2 porque once años de diabetes tipo dos es tiempo suficiente para que el páncreas llegue a este punto, con o sin todo lo que usted ha hecho bien.”

(Everything you do matters. The diet, the exercise, the metformin — that is what kept your A1C where it is instead of where it could be. Without all of that, the number would be much higher. What happens is that the disease progressed anyway, because it always progresses. You did not arrive at 11.2 because something on your part failed. You arrived at 11.2 because eleven years of type 2 diabetes is enough time for the pancreas to reach this point, with or without everything you have done well.)

What the A1C at 11.2 is doing right now

Diana does not lecture. She asks.

Diana: “¿Sabe lo que pasa en el cuerpo cuando la glucosa está elevada varios meses seguidos?”

(Do you know what happens in the body when glucose is elevated for several months in a row?)

Esperanza: “El azúcar daña los nervios y los riñones.”

(The sugar damages the nerves and the kidneys.)

Diana: “Sí. Y también los ojos y los vasos del corazón. Eso está pasando ahora. No mañana, no cuando la A1C sea 14. Ahora, con el 11.2. Cada mes que la glucosa está elevada es un mes de daño acumulado. La insulina no es el final del camino — es lo que puede detener ese daño cuando ya no hay otra opción farmacológica que lo haga.”

(Yes. And also the eyes and the vessels of the heart. That is happening now. Not tomorrow, not when the A1C is 14. Now, with 11.2. Every month that glucose is elevated is a month of accumulated damage. Insulin is not the end of the road — it is what can stop that damage when there is no other pharmacological option that can do it.)

Esperanza: “Mi hermana tomó la insulina y aún así le dañó los riñones.”

(My sister took insulin and it still damaged her kidneys.)

Diana: “Sí. Porque empezó tarde. La glucosa alta que vino antes de la insulina ya había hecho daño que no se podía revertir. La diferencia entre su hermana y usted es que usted está sentada aquí hoy, con once años de diabetes y función renal normal y visión normal. Si empezamos la insulina ahora, antes de que haya daño irreversible, la historia puede ser diferente. No igual a la de su hermana. Diferente.”

(Yes. Because she started late. The high glucose that came before the insulin had already done damage that could not be reversed. The difference between your sister and you is that you are sitting here today, with eleven years of diabetes and normal kidney function and normal vision. If we start insulin now, before there is irreversible damage, the story can be different. Not the same as your sister’s. Different.)

Esperanza is quiet for a long time.

Esperanza: “Si empiezo la insulina y no me salen los riñones, ¿cómo voy a saber si fue la insulina o si fue la suerte?”

(If I start insulin and my kidneys do not fail, how am I going to know if it was the insulin or if it was luck?)

Diana: “No va a saber. Igual que no sabemos con certeza por qué a su hermana le falló el riñón y a otra persona con la misma historia no. Pero sí sabemos lo que pasa cuando la A1C está a 11.2 durante años sin intervención. Y eso sí lo podemos controlar.”

(You will not know. Just as we do not know with certainty why your sister’s kidneys failed and another person with the same history’s did not. But we do know what happens when the A1C is at 11.2 for years without intervention. And that we can control.)

Esperanza asks to see the insulin pen. Diana shows her the needle — 4 millimeters, thinner than the vein used for a blood draw. Esperanza touches it. She sits with it for a moment.

Esperanza: “Qué chica.”

(How small.)

Diana: “La mayoría de mis pacientes me dicen que la primera vez que se inyectan piensan: ¿es eso todo? Y después me dicen que no pueden creer que esperaron tanto para algo que no duele.”

(Most of my patients tell me that the first time they inject themselves they think: is that it? And then they tell me they cannot believe they waited so long for something that does not hurt.)

They agree on a trial: basal insulin only, four units at bedtime to start, with follow-up in two weeks. A1C target: under 8 at six months. The conversation took forty-two minutes.

At the two-week follow-up, Esperanza’s fasting glucose is 168 on average — down from 224. She is still walking forty minutes every evening. She has increased the dose to seven units on her own based on Diana’s sliding scale instructions. “Lo estoy haciendo bien,” she says. (I am doing it well.) She is. At six months, her A1C is 7.4. She has not mentioned her sister in three months. She is still making tres leches on Sundays.

Scenario 2 — Carlos Morales, 44, type 1 diabetes for eighteen years, three DKA hospitalizations, construction worker, who tells every provider he takes his insulin exactly as prescribed

Elena Ramírez is a diabetes education nurse at Harris Health System’s Diabetes Self-Management Education program in Houston. She reviews Carlos’s chart before the visit: three DKA hospitalizations in twenty-four months, same insulin regimen at each discharge, no documented reason for the DKA episodes. Her clinical instinct, shaped by ten years of working in this clinic, is that three unexplained DKA episodes in a patient with an otherwise appropriate insulin regimen means one of three things: a pattern of missed doses, an infection triggering the episodes, or a supply interruption the patient is managing alone and has not told anyone about. The chart shows no documented infections at the time of any episode. She is going to look for the other two.

She spends the first fifteen minutes of the visit reviewing Carlos’s glucose log, asking about meals, exercise, his work schedule. She learns that he works six days most weeks. She learns that he checks his glucose three or four times a day. She learns that he has been on the same insulin regimen for four years and understands his carbohydrate ratio and his correction factor and has not needed adjustment of either. She asks: “¿Cuántas veces se ha olvidado de ponerse la insulina basal el último mes?” (How many times in the last month have you forgotten to give yourself the basal insulin?)

Carlos: “Nunca. Siempre me la pongo.” (Never. I always give it to myself.)

She believes him. The question she has not yet asked is different.

The question that finds rationing

Elena: “Una pregunta diferente. ¿Ha habido alguna semana o día en los últimos dos años en que el dinero no alcanzó para comprar toda la insulina que le recetaron, o cuando el seguro no la cubrió al mismo tiempo que la necesitaba?”

(A different question. Have there been any weeks or days in the last two years when the money was not enough to buy all the insulin that was prescribed for you, or when the insurance did not cover it at the same time you needed it?)

Carlos: “¿Por qué me pregunta eso?”

(Why are you asking me that?)

Elena: “Porque hay muchos pacientes con diabetes tipo uno que no tienen suficiente insulina para el mes entero y hacen lo que pueden para que les alcance. Y ninguno me lo dice hasta que pregunto así, directamente. Si eso ha pasado, quiero saberlo — no para juzgarlo, sino porque existen recursos que pueden ayudar y que tal vez no conoce.”

(Because there are many patients with type 1 diabetes who do not have enough insulin for the whole month and do what they can to make it last. And none of them tell me until I ask this way, directly. If that has happened, I want to know — not to judge you, but because there are resources that can help and that you may not know about.)

Carlos is quiet. He looks at the floor. Then he says yes.

The vial that has to last two weeks longer than it should

He explains it in full. The copay is sixty-eight dollars a vial. He uses approximately one vial every thirty days. His insurance runs on a thirty-day prescription cycle that can be refilled no earlier than the twenty-seventh day. But the prescription was written when he was discharged from the hospital and the hospital dispensed a partial vial that ran out on day twenty-two. When he called the pharmacy, the insurance had not yet authorized the new prescription. He went three days without basal insulin and tried to compensate by eating almost nothing. That was the first DKA. The second happened when the refill was delayed two weeks because his insurer required a prior authorization he did not know about and his primary care doctor’s office did not submit the paperwork until he called twice. The third happened when a truck repair took the money he had set aside for the copay and he tried to stretch the remaining insulin by reducing the dose for two weeks.

Elena: “Tres veces en dos años el sistema falló y usted fue al hospital.”

(Three times in two years the system failed and you went to the hospital.)

Carlos: “No quería decirles que la insulina no me alcanzaba. Parecía una excusa.”

(I did not want to tell them the insulin was not enough. It seemed like an excuse.)

Elena: “No es una excusa. Es lo que pasa cuando el costo de la insulina excede lo que el presupuesto puede cubrir ese mes. Eso es una emergencia silenciosa que le pasa a miles de pacientes con diabetes tipo uno en Texas. El problema es que el cuerpo no distingue entre la cetoaci[d]osis que viene de no poner ninguna insulina y la que viene de poner la mitad. El riesgo es el mismo.”

(It is not an excuse. It is what happens when the cost of insulin exceeds what the budget can cover that month. That is a silent emergency that happens to thousands of patients with type 1 diabetes in Texas. The problem is that the body does not distinguish between the ketoacidosis that comes from giving no insulin and the one that comes from giving half. The risk is the same.)

The minimum dose the body needs and what happens below it

Elena explains the mechanism. Basal insulin is not optional in type 1 diabetes. The pancreas produces zero insulin. Basal insulin provides the floor that prevents the liver from releasing glucose continuously and prevents fat cells from breaking down into ketones. Without that floor — or with that floor reduced below a critical minimum — the metabolic shift toward ketone production begins within hours. The minimum basal dose varies by individual, but reducing from twenty-eight to twelve units may fall below that individual’s floor. The body then moves into a state of starvation metabolism despite food intake. Glucose rises. Ketones accumulate. DKA.

Elena: “Si hay un mes en que la insulina no alcanza, quiero saber antes de que llegue a ese punto. No después del hospital. Antes. ¿Puedo darle mi número directo?”

(If there is a month when the insulin is not enough, I want to know before you reach that point. Not after the hospital. Before. Can I give you my direct number?)

Carlos: “Sí.”

The programs that change the cost of staying alive

Elena pulls up a printed resource sheet she keeps for exactly this conversation. She goes through it with Carlos.

Eli Lilly Insulin Value Program: Humalog available for thirty-five dollars per month regardless of insurance status. He is on Humalog for his bolus doses — this applies. She hands him the application form, already printed in Spanish. She writes the website on a prescription pad: insulinaffordability.com.

For the glargine: Sanofi Insulins Valyou Savings Program covers Lantus and Toujeo for ninety-nine dollars per month for up to ten boxes or vials. He is on Lantus brand. She shows him the enrollment form.

She also tells him about the federally qualified health center at 2239 Canal Street that uses 340B pricing — a federal drug discount program that can reduce his insulin costs to a fraction of the retail price if he establishes care there as a primary provider. It accepts patients regardless of immigration status or ability to pay, on a sliding fee scale.

Elena: “Esto no elimina el costo. Pero puede reducirlo de sesenta y ocho dólares a treinta y cinco dólares al mes para la insulina rápida. Eso es una diferencia real. Y el centro de salud en Canal tiene precios de descuento federal para la insulina lenta.”

(This does not eliminate the cost. But it can reduce it from sixty-eight dollars to thirty-five dollars per month for the fast insulin. That is a real difference. And the health center on Canal has federal discount prices for the slow insulin.)

Before Carlos leaves, Elena goes over the DKA warning signs one more time, explicitly, in Spanish: excessive thirst and urination that feels different from normal, nausea or vomiting, fruity smell on the breath, fast or difficult breathing, confusion. “Estos son los síntomas que significan ir a urgencias de inmediato — no llamarme, no esperar, urgencias.” (These are the symptoms that mean go to the emergency room immediately — not call me, not wait, emergency room.)

She also gives him a protocol for low-insulin periods: if he is running short and cannot refill, she wants to know, and they will work out a reduced-dose plan together that keeps him above the metabolic floor — rather than him making the adjustment alone in the dark, rationing by guesswork.

Carlos has not been hospitalized since this visit. He has called the direct line twice: once in September when a prior authorization was delayed and once in February when the Humalog cost more than the $35 cap because the pharmacy initially applied it wrong and she helped him get the billing corrected. Both times, he called before his glucose reached 400.

Scenario 3 — Rosa Jiménez, 67, type 2 diabetes for nine years, A1C 9.1, retired schoolteacher, who has eighteen months of glucose logs and has never been told what to do with the numbers

Andrés Leal has been a diabetes education nurse at the University of New Mexico Diabetes Comprehensive Care Center for six years. He reviews Rosa’s chart before the visit: nine years of type 2 diabetes, stable two-drug regimen, A1C oscillating between 8.8 and 9.4, consistent clinic attendance. He reviews the prior visit notes. They all say the same thing: “Patient monitors blood glucose as directed. A1C 9.1. Continue current regimen. Return in 3 months.” He notes that Rosa is a retired schoolteacher. He thinks about what a retired schoolteacher does when she is given an assignment: she does it. She checks her glucose. She writes it down. She brings the notebook. She has done everything she was told to do. No one has given her the next assignment.

He introduces himself. He asks Rosa about the notebook. She hands it to him. He looks at it for two minutes without saying anything. It is genuinely impressive: eighteen months of dates, fasting glucose, post-dinner glucose, occasional postmeal glucose when she remembers to check, a column of notes. He finds a page from two months ago and reads across a row: 247 after breakfast. He finds another: 189 before dinner. He finds the 73 on a Wednesday in April, with the note “no comí bien ese día” (did not eat well that day).

Andrés: “Este registro es excepcional. Diecioch[o] meses sin faltar un día.”

(This record is exceptional. Eighteen months without missing a day.)

Rosa: “Me dijeron que lo anotara. Siempre lo anoto.”

(They told me to write it down. I always write it down.)

Andrés: “Y cuando anotó el 247 ese martes de desayuno, ¿qué hizo diferente ese día?”

(And when you wrote down the 247 that Tuesday at breakfast, what did you do differently that day?)

Rosa: “Nada. No sabía qué hacer. Lo anoté y desayuné.”

(Nothing. I did not know what to do. I wrote it down and had breakfast.)

Converting a record into a decision

Andrés: “Nadie le ha explicado lo que significan los números en términos de lo que hace después. No es una crítica — es algo que debería haber pasado hace nueve años y que vamos a hacer hoy. Este registro no es solo una historia del pasado. Es información que le dice cómo está respondiendo su cuerpo. Y esa información tiene consecuencias concretas — cosas que se pueden hacer diferente.”

(No one has explained to you what the numbers mean in terms of what you do next. That is not a criticism — it is something that should have happened nine years ago and that we are going to do today. This record is not just a history of the past. It is information that tells you how your body is responding. And that information has concrete consequences — things that can be done differently.)

He opens the notebook to the most recent two weeks. He points to the fasting column.

Andrés: “Este número de la mañana, antes de desayunar — el rango que buscamos es de 70 a 130. Este número me dice dos cosas: cómo trabajó el medicamento de la noche, y si la cena de anoche fue lo que el cuerpo pudo manejar. ¿Ve este número aquí — el 178 del lunes?”

(This morning number, before breakfast — the range we are looking for is 70 to 130. This number tells me two things: how the nighttime medication worked, and whether last night’s dinner was something the body could handle. Do you see this number here — the 178 from Monday?)

Rosa: “Sí. Ese día comí tamales.”

(Yes. That day I ate tamales.)

Andrés: “Los tamales son un alimento con mucho almidón — el cuerpo los convierte en glucosa rápidamente. El 178 de la mañana me dice que la cena del domingo fue mayor de lo que la sitagliptina pudo manejar esa noche. No es que los tamales estén prohibidos — es que si los come de noche, el número de la mañana va a ser más alto, y eso es información que podemos usar para decidir quién come los tamales o a qué hora.”

(Tamales are a food with a lot of starch — the body converts them to glucose quickly. The 178 in the morning tells me that Sunday’s dinner was more than the sitagliptin could handle that night. It is not that tamales are forbidden — it is that if you eat them at night, the morning number is going to be higher, and that is information we can use to decide who eats the tamales or at what time.)

Rosa: “¿Y si los como al mediodía?”

(And if I eat them at noon?)

Andrés: “Exacto. Si los come al mediodía y camina cuarenta minutos después, el cuerpo usa parte de esa glucosa con el movimiento y el número del mediodía puede ser más controlable. El número de la mañana siguiente también va a ser mejor. El registro que tiene le puede decir si eso es cierto — pruebe los tamales al mediodía, camine después, vea el número de la mañana siguiente. Es un experimento.”

(Exactly. If you eat them at noon and walk forty minutes afterward, the body uses some of that glucose with the movement and the midday number can be more manageable. The next morning number is also going to be better. The record you have can tell you if that is true — try tamales at noon, walk afterward, see the next morning number. It is an experiment.)

Rosa looks at the notebook with a different expression. She has kept eighteen months of data. She has just been told it contains an experiment she can run.

The number that means act now versus the number that means bring the pattern

Andrés shows her the 73 from April. He asks what she did.

Rosa: “Nada. Anoté que no había comido bien ese día.”

(Nothing. I wrote that I had not eaten well that day.)

Andrés: “Este número me preocupa un poco. El 73 en sí está en el límite inferior del rango normal. Pero si usted tiene síntomas cuando lo ve — temblor, sudor frío, hambre repentina, mareo — ese número se trata inmediatamente, aunque sea 73. ¿Tuvo síntomas ese día?”

(This number concerns me a little. The 73 by itself is at the lower end of the normal range. But if you have symptoms when you see it — trembling, cold sweat, sudden hunger, dizziness — that number is treated immediately, even if it is 73. Did you have symptoms that day?)

Rosa: “Estaba un poco temblando. Pensé que era hambre.”

(I was trembling a little. I thought it was hunger.)

Andrés: “Era hipoglucemia. Cuatro onzas de jugo — no más, no menos, cuatro onzas — y espere quince minutos y vuelva a revisar. Si el número sube a 100 y los síntomas se van, siga el día normal. Si el número no sube o los síntomas se quedan, llame al clínica inmediatamente.”

(That was hypoglycemia. Four ounces of juice — not more, not less, four ounces — and wait fifteen minutes and recheck. If the number goes up to 100 and the symptoms go away, continue the normal day. If the number does not go up or the symptoms stay, call the clinic immediately.)

Rosa writes this down. In her teacher’s handwriting, precise and level.

The two numbers that belong on the refrigerator door

Before Rosa leaves, Andrés gives her a card with two action thresholds written on it, in Spanish:

Menos de 70 con síntomas: cuatro onzas de jugo ahora, revisar en 15 minutos.

(Below 70 with symptoms: four ounces of juice now, recheck in 15 minutes.)

Más de 300: llamar al clínica inmediatamente, no esperar la próxima cita.

(Above 300: call the clinic immediately, do not wait for the next appointment.)

Entre 130 y 300 sin síntomas: anotar el patrón, trae[r]lo a la próxima cita.

(Between 130 and 300 without symptoms: write down the pattern, bring it to the next appointment.)

Rosa: “¿Debo pegar esto en el refrigerador?”

(Should I stick this on the refrigerator?)

Andrés: “Exactamente.”

(Exactly.)

At the three-month follow-up, Rosa arrives with the notebook and a new column she has added to the log: what she ate for dinner the night before and whether she walked. She has been running the tamale experiment on her own. She tried tamales at noon twice and walked afterward both times. She brings the data. The next morning number was 134 and 141. She had tamales at dinner once: the next morning number was 212. “Ya lo sabía que iba a pasar,” she says. (I already knew it was going to happen.) Her A1C at three months is 8.3. At six months it is 7.9. She will not get an A in diabetes from anyone. But she knows how to read the test.

Key phrases for diabetes education nurses working in Spanish

Addressing insulin refusal: “La insulina no es el medicamento que le dan cuando no lo intentó suficiente. Es el medicamento que le dan cuando el páncreas ya no puede producir suficiente por sí mismo.” (Insulin is not the medication they give you when you did not try hard enough. It is the medication they give you when the pancreas can no longer produce enough on its own.)

Explaining disease progression without blame: “La diabetes tipo dos avanza sola — el páncreas produce menos insulina cada año, independientemente de lo que usted coma o haga. La A1C no es una calificación de comportamiento — es una medida de dónde está la enfermedad.” (Type 2 diabetes progresses on its own — the pancreas produces less insulin each year, regardless of what you eat or do. The A1C is not a grade of behavior — it is a measure of where the disease is.)

Finding insulin rationing: “¿Ha habido alguna semana o día en que el dinero no alcanzó para comprar toda la insulina que le recetaron, o cuando el seguro no la cubrió a tiempo?” (Have there been any weeks or days when the money was not enough to buy all the insulin that was prescribed for you, or when the insurance did not cover it in time?)

DKA safety threshold: “La insulina basal no es opcional en la diabetes tipo uno. Reduce la dosis porque no alcanza y el cuerpo empieza a producir cetonas en horas. Esos son los síntomas: mucha sed, mucha orina, náuseas, aliento con olor a fruta, respiración rápida. Esos síntomas son urgencias — no llamarme, urgencias.” (Basal insulin is not optional in type 1 diabetes. Reduce the dose because it runs out and the body starts producing ketones in hours. Those are the symptoms: excessive thirst, excessive urination, nausea, fruity-smelling breath, rapid breathing. Those symptoms are emergencies — not call me, emergency room.)

Teaching a glucose log as a decision tool: “Este número no es solo información — es una pregunta que tiene respuesta. ¿Qué hago cuando el número de la mañana está por encima de 130? ¿Qué hago cuando el número está por debajo de 70 con síntomas? Esas son las preguntas que quiero que pueda responder antes de salir de aquí.” (This number is not just information — it is a question that has an answer. What do I do when the morning number is above 130? What do I do when the number is below 70 with symptoms? Those are the questions I want you to be able to answer before you leave here.)

Hypoglycemia action: “El número debajo de 70 con síntomas se trata ahora: cuatro onzas de jugo, espera quince minutos, vuelve a revisar. No más que eso, no menos que eso. Cuatro onzas.” (A number below 70 with symptoms is treated now: four ounces of juice, wait fifteen minutes, recheck. Not more than that, not less than that. Four ounces.)

Opening question for any glucose log review: “Cuando anotó este número, ¿qué hizo después?” (When you wrote down this number, what did you do next?) The answer to this question tells the nurse everything about what the patient understands.

Practice these and more than 200 other clinical conversations in Spanish at ClinicaLingo.